Compare PDD Holdings Inc. American Depositary Shares (PDD) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PDD Holdings Inc. American Depositary Shares vs Smith & Nephew plc — how do they compare? PDD Holdings Inc. American Depositary Shares trades at $79.19 (market cap $111.40B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: PDD Holdings Inc. American Depositary Shares is far larger — about 10× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.95% dividend while PDD Holdings Inc. American Depositary Shares pays none. Which is the better fit depends on your goals.
| PDD | SNN | |
|---|---|---|
Market Cap | $111.40B | $11.10B |
Volume | 4,823,275 | 1,051,703 |
Sector | Consumer Cyclical | Health |
52-Week High | $138.13 | $37.17 |
52-Week Low | $73.30 | $26.42 |
Enterprise Value | $44.04B | $14.13B |
Typical Hold Time | — | 120 Days |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Smith & Nephew (SNN) trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio, though the stock faces headwinds from analyst downgrades and CFO departure news.
The outlook is cautious; while fundamentals show profitability growth, the stock's proximity to lows and mixed analyst sentiment (26% buy, 65% hold) suggest limited near-term upside. Key risks include competitive pressures and execution challenges, but the stable dividend and institutional interest offer some support for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About PDD Holdings Inc. American Depositary Shares
PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. Its sourcing, logistics, and fulfillment network supports those businesses and their commerce operations.
Read more on PDD →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
